VAIA
WST icon

Virtus Alternative Investment Advisers’s West Pharmaceutical WST Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20
Closed -$6K – 231
2020
Q4 		$6K Sell
20
-98
-83% -$27.5K 0.09% 230
2020
Q3 		$29K Buy
118
+40
+51% +$10.6K 0.53% 34
2020
Q2 		$18K Sell
78
-74
-49% -$14.5K 0.28% 77
2020
Q1 		$23K Buy
152
+92
+153% +$14.2K 0.32% 79
2019
Q4 		$9K Buy
+60
New +$8.74K 0.14% 200

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtus Alternative Investment Advisers's WST Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of West Pharmaceutical (WST) in Q1 2021, closing a stake of 20 shares — an estimated $6K sold.

Virtus Alternative Investment Advisers first reported a position in WST in Q4 2019 and held it in 5 quarters. The position peaked at $29K in Q3 2020. 590 funds tracked by Wall St. Rank hold WST as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining West Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 20 West Pharmaceutical shares in Q1 2021, an estimated $6K.
  • Virtus Alternative Investment Advisers first reported a position in West Pharmaceutical in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's West Pharmaceutical position peaked at $29K in Q3 2020.
  • 590 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.